Your browser doesn't support javascript.
loading
Comparative efficacy and safety of first-line treatments for advanced non-small cell lung cancer with ALK-rearranged: a meta-analysis of clinical trials.
Ma, Hao-Chuan; Liu, Yi-Hong; Ding, Kai-Lin; Liu, Yu-Feng; Zhao, Wen-Jie; Zhu, Yan-Juan; Chang, Xue-Song; Chen, Ya-Dong; Xiao, Zhen-Zhen; Yu, Ya-Ya; Zhou, Rui; Zhang, Hai-Bo.
Afiliação
  • Ma HC; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.
  • Liu YH; The Second Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.
  • Ding KL; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.
  • Liu YF; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.
  • Zhao WJ; The Second Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.
  • Zhu YJ; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.
  • Chang XS; The Second Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.
  • Chen YD; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.
  • Xiao ZZ; The Second Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.
  • Yu YY; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.
  • Zhou R; The Second Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.
  • Zhang HB; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.
BMC Cancer ; 21(1): 1278, 2021 Nov 26.
Article em En | MEDLINE | ID: mdl-34836510
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rearranjo Gênico / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Quinase do Linfoma Anaplásico / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Clinical_trials / Systematic_reviews Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rearranjo Gênico / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Quinase do Linfoma Anaplásico / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Clinical_trials / Systematic_reviews Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China